Novo Nordisk
Entity.
- Evidence
- 117 documents · 45 separate publishers
- Standing
- A name from our starting list; its record is kept up to date automatically from coverage
- Time
- first seen 3 Sept 2026, last seen 7 Oct 2026
- Measured
- 25% of mentions say something specific about it; the rest only name it
- As of
- 8 Oct 2026
Where this comes from
- The Cryptonomist · 2026-09-29 · Novo Nordisk stock is oversold, but is the 70% collapse from its peak over? (opens the source in a new tab)
- The Clinical Trial Vanguard · 2026-09-29 · Novo Nordisk Licenses Oral GLP-1/GIP Dual Agonist HRS-1596 From Hengrui for $300M (opens the source in a new tab)
- MarketBeat News Feed · 2026-09-29 · Novo Nordisk A/S (NYSE:NVO) Stock Sold Off by Rep. Kevin Hern (opens the source in a new tab)
- MarketBeat News Feed · 2026-09-25 · Novo Nordisk A/S (NYSE:NVO) Stock Rated "Hold" by Sell-Side Brokerages (opens the source in a new tab)
- Fortune · 2026-09-23 · U.S. demand for Novo Nordisk’s weight loss drugs is so huge that the Danish central bank just doubled the nation’s entire growth forecast (opens the source in a new tab)
- MarketWatch · 2026-09-21 · Novo Nordisk’s stock tumbles as doubts persist about Ozempic maker’s goals for 2030 (opens the source in a new tab)
- 24/7 Wall St. · 2026-09-16 · Novo Nordisk Expands Obesity Drug to Children, But Market Hesitates on Adoption (opens the source in a new tab)
- MarketBeat News Feed · 2026-09-13 · The Manufacturers Life Insurance Company Boosts Stock Holdings in Novo Nordisk A/S $NVO (opens the source in a new tab)
- STAT News · 2026-09-11 · STAT+: Novartis, Novo Nordisk drug failures will likely ‘pop a hole in the balloon’ of the field (opens the source in a new tab)
- MarketBeat News Feed · 2026-09-09 · Teamwork Financial Advisors LLC Has $244,000 Stock Position in Novo Nordisk A/S $NVO (opens the source in a new tab)